Skip to content
★ Sign in to follow
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 16 Sept 2024 for Reckitt Benckiser Group plc, €10k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Pat Sly: trading record in brief

This profile gathers the share dealings of Pat Sly in Reckitt Benckiser Group plc. Between 15 September 2023 and 13 September 2024, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 16 September 2024, the filings show a share grant worth €10k in Reckitt Benckiser Group plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Pat Sly

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◆
    President HealthExecutivesReckitt Benckiser Group plc
    8,755 GBP44RNS
    190 shares@ £46.078737.1% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77RNS:5351186-3
  • ◆
    President HealthExecutivesReckitt Benckiser Group plc
    9,077 GBP44RNS
    205 shares@ £44.277138.1% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77RNS:5200506-3
  • ◆
    President HealthExecutivesReckitt Benckiser Group plc
    5,955 GBP42RNS
    103 shares@ £57.819624.8% of flowLondon Stock Exchange, Main Market - XLONISIN GB00B24CGK77RNS:4903465-3

3 of 3 declarations